Evaluation of Autoantibodies to Common and Neuronal Cell Antigens in CFS

Research Article:

Evaluation of Autoantibodies to Common and Neuronal Cell Antigens in Chronic Fatigue Syndrome.

Journal: J Autoimmune Dis. 2005 May 25;2(1):5

Authors: Vernon SD, Reeves WC.

NLM Citation: PMID: 15916704

People with chronic fatigue syndrome (CFS) suffer from multiple symptoms including fatigue, impaired memory and concentration, unrefreshing sleep and musculoskeletal pain. The exact causes of CFS are not known, but the symptom complex resembles that of several diseases that affect the immune system and autoantibodies may provide clues to the various etiologies of CFS.

We used ELISA, immunoblot and commercially available assays to test serum from subjects enrolled in a physician-based surveillance study conducted in Atlanta, Georgia and a population-based study in Wichita, Kansas for a number of common autoantibodies and antibodies to neuron specific antigens.

Subsets of those with CFS had higher rates of antibodies to microtubule-associated protein 2 (MAP2) (p = 0.03) and ssDNA (p = 0.04). There was no evidence of higher rates for several common nuclear and cellular antigens in people with CFS.

Autoantibodies to specific host cell antigens may be a useful approach for identifying subsets of people with CFS, identify biomarkers, and provide clues to CFS etiologies.

[Full text in PDF format]

[Return to index]